Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ken Herrmann

Showing results (51-60 of 721) with videos related to

Pageof 73
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN|February 19, 2015
Value of functional imaging by PET in esophageal cancerThomas Schmidt, Florian Lordick, Ken Herrmann, et al.
Therapeutics and Clinical Risk Management|July 2, 2020
Diagnosis and Screening of Patients with Fabry DiseaseIrfan Vardarli, Christoph Rischpler, Ken Herrmann, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 23, 2025
Advancing Tomorrow's Cancer Medicines: Jacob Van Naarden Talks with Ken Herrmann and Johannes Czernin About Corporate Approaches to New Therapeutics DevelopmentJacob S Van Naarden, Ken Herrmann, Johannes Czernin
Visceral Medicine|November 28, 2017
Neuroendocrine Tumors of the Gastrointestinal TractAndrea Frilling, Ken Herrmann, Daniel Kämmerer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 3, 2017
Theranostic Concepts: More Than Just a Fashion Trend-Introduction and OverviewKen Herrmann, Steven M Larson, Wolfgang A Weber
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 21, 2026
Targeted Radiopharmaceutical Therapy: Advances, Investment Dynamics, and Future Directions-Part 2Catello Somma, Richard Zimmermann, Germo Gericke, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 26, 2023
Defining the role of nuclear medicine in haematological tumours-EANM Focus 4: consensus on molecular imaging and therapy in haematological tumoursCristina Nanni, Carsten Kobe, Ken Herrmann, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 1, 2024
Kick-Starting Molecular Theranostics in Renal Cell CarcinomaViktor Grünwald, Boris Hadschik, Niklas Klümper, et al.
Methods in Molecular Biology (Clifton, N.J.)|February 19, 2011
PET and PET-CT in esophageal and gastric cancerHinrich A Wieder, Bernd J Krause, Ken Herrmann
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 5, 2019
Driving the Future of Nuclear MedicineKen Herrmann, Patrick Veit-Haibach, Wolfgang A Weber
Pageof 73

Showing results (51-60 of 721) with videos related to

Sort By:
Pageof 73
Journal of the National Comprehensive Cancer Network : JNCCN|February 19, 2015
Value of functional imaging by PET in esophageal cancerThomas Schmidt, Florian Lordick, Ken Herrmann, et al.
Therapeutics and Clinical Risk Management|July 2, 2020
Diagnosis and Screening of Patients with Fabry DiseaseIrfan Vardarli, Christoph Rischpler, Ken Herrmann, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 23, 2025
Advancing Tomorrow's Cancer Medicines: Jacob Van Naarden Talks with Ken Herrmann and Johannes Czernin About Corporate Approaches to New Therapeutics DevelopmentJacob S Van Naarden, Ken Herrmann, Johannes Czernin
Visceral Medicine|November 28, 2017
Neuroendocrine Tumors of the Gastrointestinal TractAndrea Frilling, Ken Herrmann, Daniel Kämmerer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 3, 2017
Theranostic Concepts: More Than Just a Fashion Trend-Introduction and OverviewKen Herrmann, Steven M Larson, Wolfgang A Weber
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 21, 2026
Targeted Radiopharmaceutical Therapy: Advances, Investment Dynamics, and Future Directions-Part 2Catello Somma, Richard Zimmermann, Germo Gericke, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 26, 2023
Defining the role of nuclear medicine in haematological tumours-EANM Focus 4: consensus on molecular imaging and therapy in haematological tumoursCristina Nanni, Carsten Kobe, Ken Herrmann, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 1, 2024
Kick-Starting Molecular Theranostics in Renal Cell CarcinomaViktor Grünwald, Boris Hadschik, Niklas Klümper, et al.
Methods in Molecular Biology (Clifton, N.J.)|February 19, 2011
PET and PET-CT in esophageal and gastric cancerHinrich A Wieder, Bernd J Krause, Ken Herrmann
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 5, 2019
Driving the Future of Nuclear MedicineKen Herrmann, Patrick Veit-Haibach, Wolfgang A Weber
Pageof 73